NYSE - Nasdaq Real Time Price USD

Enhabit, Inc. (EHAB)

Compare
8.52 0.00 (0.00%)
At close: December 13 at 4:00:02 PM EST
8.52 -0.01 (-0.11%)
After hours: December 13 at 4:00:15 PM EST
Loading Chart for EHAB
DELL
  • Previous Close 8.52
  • Open 8.64
  • Bid 8.48 x 800
  • Ask 8.49 x 800
  • Day's Range 8.33 - 8.60
  • 52 Week Range 6.85 - 11.74
  • Volume 207,556
  • Avg. Volume 592,942
  • Market Cap (intraday) 428.421M
  • Beta (5Y Monthly) 1.38
  • PE Ratio (TTM) --
  • EPS (TTM) -2.33
  • Earnings Date Mar 4, 2025 - Mar 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.90

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

www.ehab.com

10,800

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EHAB

View More

Performance Overview: EHAB

Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EHAB
17.68%
S&P 500
26.86%

1-Year Return

EHAB
20.89%
S&P 500
30.31%

3-Year Return

EHAB
65.92%
S&P 500
28.42%

5-Year Return

EHAB
65.92%
S&P 500
90.97%

Compare To: EHAB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EHAB

View More

Valuation Measures

Annual
As of 12/13/2024
  • Market Cap

    428.42M

  • Enterprise Value

    963.72M

  • Trailing P/E

    --

  • Forward P/E

    30.12

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.41

  • Price/Book (mrq)

    0.76

  • Enterprise Value/Revenue

    0.93

  • Enterprise Value/EBITDA

    14.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.24%

  • Return on Assets (ttm)

    1.77%

  • Return on Equity (ttm)

    -17.46%

  • Revenue (ttm)

    1.04B

  • Net Income Avi to Common (ttm)

    -116.6M

  • Diluted EPS (ttm)

    -2.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    45.7M

  • Total Debt/Equity (mrq)

    97.36%

  • Levered Free Cash Flow (ttm)

    57.33M

Research Analysis: EHAB

View More

Company Insights: EHAB

Research Reports: EHAB

View More

People Also Watch